Pulmonary non-tuberculous mycobacterial infection
MONDO:0018469Also known as: Nontuberculous Mycobacterial Lung Disease, non-tuberculous mycobacterial lung disease, nontuberculous mycobacterial lung disease
90 clinical trials for this condition and its sub-types, 48 tagged with Pulmonary non-tuberculous mycobacterial infection itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
New hope for stubborn lung infection? trial of epetraborole begins, then stops
Disease control Stopped earlyThis study tested an oral drug called epetraborole for people with a tough-to-treat lung infection called MAC lung disease. The trial aimed to see if adding epetraborole to standard treatment could improve symptoms and clear the infection. However, the study was terminated early,…
Phase 2/3 • Sponsor: AN2 Therapeutics, Inc • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New inhaled drug aimed at stubborn lung infection shows promise, but trial halted early
Disease control Stopped earlyThis phase 3 study tested an inhaled form of the antibiotic clofazimine added to standard therapy for people with MAC lung disease that did not respond to previous treatment. The goal was to see if the drug could clear the infection from sputum cultures and improve quality of lif…
Phase 3 • Sponsor: Mannkind Corporation • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC